NEW INSIGHTS IN ALZHEIMER’S DISEASE: THE USE OF STEM CELLS
P. Galasso1*, P. Felaco2 and M.M. Corsi-Romanelli3,4 1 Aesthetic Medicine and Oral Medicine, “Gabriele d’Annunzio” University of Chieti-Pescara, Chieti, Italy;...
EJND 2025 Vol. 14 issue n. 3
PD-1 AND ANTI-PD-1 ANTIBODIES DURING INFECTIONS OF THE CENTRAL NERVOUS SYSTEM
S. Stuard1 and M. Rosati2* 1 Global Medical Office, FMC Germany, Bad Homburg, Germany; 2 Department of Obstetrics and Gynecology,...
THE ACTIVATION OF TLR OR IL-1R IN MICROGLIA MEDIATES NEUROINFLAMMATION THROUGH IRAK
A. Avivar-Valderas1* and M.J. Conti2 1 Takeda, Cell therapy sciences, Tres Cantos, Madrid, Spain; 2 Faculty of Medicine, S. Andrea...
ADVANCES FOR AMYOTROPHIC LATERAL SCLEROSIS: DOES IPL344 SLOW THE PROGRESSION?
Letter to the Editor M.G. Onesta* Unipolar Spinal Unit, Physical Medicine and Rehabilitation, Cannizzaro Emergency Hospital of Catania, Italy. *Correspondence...
CELLULAR AND VASCULAR MECHANISMS IN NEURODEGENERATION
S. Lomoio* Alzheimer’s Disease Research Laboratory, Department of Neuroscience, Tufts University School of Medicine, Boston, United States. *Correspondence to: Selene...
THE BLOOD-BRAIN BARRIER IS HIGHLY SPECIALIZED TO PROTECT THE BRAIN
D. Kempuraj* Research Laboratory at the Institute for Neuroimmune Medicine, Nova Southeastern University, Florida, USA. *Correspondence to: Duraisamy Kempuraj, Research...